DGXQuest Diagnostics

$255.60+47% 1Y
Latest close: a new 52-week highNov 6, 2026what changed →

The business

How DGX's business earns

Quest Diagnostics earns 11% on the capital it employs against an estimated 9.0% cost of capital.

11%

Return on invested capital · cost of capital 9.0% · 2.0 points above the estimated cost of capital

Operating margin
15%

Operating margin · Diagnostics & Research median 7.1% · 12 months to Sep 30, 2026

Cash conversion
1.47×

Cash conversion · 1.61× a year ago · operating cash flow divided by operating profit after tax

Share count, year on year
−0.88%

Share count, year on year · within 1% of a year ago

Operating margin by fiscal year
Operating margin by fiscal year
YearOperating margin
FY202021%
FY202122%
FY202214%
FY202314%
FY202414%
FY202514%
Details›
Gross margin12 months to Sep 30, 2026
33%
Operating margin12 months to Sep 30, 2026
15%
Net margin12 months to Sep 30, 2026
9.5%
Free cash flow margin
12%
Revenue, trailing twelve months
$11.8B
Free cash flow, trailing twelve months
$1.38B
Net income, trailing twelve months
$1.13B
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
11%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

Quest Diagnostics (DGX) Margins and Return on Capital · Ryufin